Current Traditional Medicine

Dr. Wei Wang is a Distinguished Furong Professor at School of Pharmacy, Hunan University of Chinese Medicine. He did his B.S (Chinese Materia Medica) and M.S (Pharmaceutics) from Hunan University of Chinese, during 1990-1997. He obtained his Ph.D. in Pharmacognosy from Peking University in 2006. His research fields include Natural Products Chemistry, TCM and Ethnomedicine, Organic Chemistry, Analytical and Spectroscopy. Dr. Wang has 78 publications and 6 patents to his credit.

Prof. Atta-ur-Rahman, Ph.D. in organic chemistry (Cambridge University, 1968), has over 1,055 international publications including 210 books. He won the UNESCO Science Prize (1999) and was elected Fellow of Royal Society (London, 2006). He was conferred honorary doctorate degrees by many universities including Cambridge University and many others. Furthermore, Prof. Atta-ur-Rahman was elected Honorary Life Fellow of Kings College, Cambridge University, and the Austrian government honoured him with its high civil award “Grosse Goldene Ehrenzeischen am Bande" (2007). He is the only scientist from the Muslim world to be Foreign Fellow (“Academician”) of Chinese and Korean Academies of Sciences. The University of Technology Mara (UiTM), Malaysia, has established “Atta-ur-Rahman Institute of Natural Product Discovery” in his honour. Prof. Atta-ur-Rahman was the Federal Minister of Science and Technology of Pakistan, and he is Chairman of UN Committee on Science, Technology and Innovation for UNESCAP region covering 62 countries.

Prof. KO, Seong-Gyu is the faculty and Vice Dean of College of Korean Medicine and Director of East-West Medical Research Institute at the Kyung Hee University, Seoul, KOREA. He is currently working as a chairperson of IRB of Kyung Hee University, and a head professor of Brain Korea 21 plus project center supported by the Ministry of Education of Korea. He is actively working with government organization of Ministry of Health and Welfare (MoHW), Ministry of Food and Drug Safety (MFDS) , Korea Institute of Oriental Medicine (KIOM) as a committee member or board member for regulation, development, evaluation and planning.

Dr. Lee has worked on numerous drug discovery projects related to traditional Chinese medicine, contributing significantly to the development of alternative therapies for substance abuse and for osteoarthritis. He is the principal investigator on “Alternative Therapies for Alcohol and Drug Abuse,” a program project grant funded by the National Institutes of Health. Dr. Lee served as co-principal investigator on the development of the herbal remedy HLXL for treating osteoarthritis. Dr. Lee received an institutional development award in 1985, has published 110 papers and holds 15 US and international patents.

Dr. Lin obtained Ph.D. in Medicinal Chemistry from Shenyang Pharmaceutical University, China. Currently Dr. Lin is a distinguished professor and the Yangtze River Scholar Professor at State Key Laboratory of Oncogenes and Related Genes, and also the Director of Department of Clinical Pharmacy of Renji hospital, School of Medicine, Shanghai Jiao Tong University. Dr. Lin’s research is involved in discovery of marine natural products, structure optimization, chemical synthesis and biosynthesis of active natural products, and MOA of marine antitumor molecules. He is a named inventor of 30 issued patents and has published more than 100 scientific articles as corresponding author.

Dr. Löbenberg holds a BS in pharmacy from the Johannes Gutenberg-University in Mainz, Germany. He received his PhD in pharmaceutics from the Johann Wolfgang Goethe-University in Frankfurt and is currently professor at the University of Alberta. His research interests are in Biopharmaceutics to predict the oral performance of drugs and botanicals and in inhalable nanoparticles to treat lung cancer and tropical diseases. He is founder and director of the Drug Development and Innovation Centre at the University of Alberta.

Prof. Xiao, director of China Military Institute of Chinese Materia Medica and director of Integrative Medical Centre in 302 Military Hospital. He has been engaging in clinical pharmacy of traditional Chinese medicines. He is a committee member of Chinese Pharmacopoeia Commission, and was selected as the First Ten Outstanding Youth of Traditional Chinese Medicine. Prof. Xiao has won 2 items of the National Award of Science and Technology of China as the first achiever. He has developed 2 new drugs for treating liver diseases. He has published more than 330 pieces of scientific publications. Prof. Xiao has also established Guideline for Diagnosis and Treatment of Herb-Induced Liver Injury as well as Guidelines for the Evaluation of the Quality of TCM. He is a named inventor of 32 issued domestic and foreign patents.

Prof. Alvaro Viljoen obtained his Ph.D. (1999) on the secondary metabolites of the genus Aloe from the University of Johannesburg. He identified medicinal aromatic plants as a potential research opportunity, especially in South Africa. His commitment to phytomedicine research was recently acknowledged through the 2013 TWAS-ROSSA Award from The World Academy of Sciences. He has contributed to 185 peer-reviewed papers, mostly on aspects of medicinal plant research. The highlight of his academic career has been his nomination for a National Research Chair in Phytomedicine, which was awarded by the NRF/DST in 2013, a position he holds concurrently as Director of the recently awarded MRC Herbal Drugs Research Unit in South Africa.

Prof. El-Seedi obtained a doctorate (Ph.D.) in Organic Chemistry, Channel program with Kemisk Institute, Aarhus University, Denmark / Menoufia University, Egypt. Prof. El-Seedi is a former fellow of the Japanese Society of Promotion of Science as a visiting assistant professor, Department of Chemistry, Faculty of Science and Technology, Keio University, Japan. Prof. El-Seedi worked in internationally recognized laboratories including Kunglia Tekniska hogskola (KTH), Stockholm, Sweden, Uppsala Biomedical Center, Uppsala University, Sweden, University of Malaya, and Menoufia University, Egypt. Prof. El-Seedi has published more than 100 scientific publications including one paper in The Lancet.

Prof. Cai obtained his Ph.D. degree in Pharmacology of Chinese Medicine from the Hong Kong Baptist University (HKBU), and pursued his postdoctoral training in molecular biology and genetics at the National Institutes of Health (NIH). Prof. Cai currently serves as a director of the Hunan Provincial Key Laboratory of Diagnostic and Therapeutic Research in Chinese Medicine, Hunan University of Chinese Medicine. Prof. Cai has authored or co-authored more than 30 peer-reviewed papers including those published in Am J Respir Crit Care Med, Chest, BBRC, and J Ethnopharmacol, and his research contribution has been recognized by multiple national and international awards.

Dr. Deliang Cao obtained his Ph.D. degree (1996) in Molecular Biology from University of Hong Kong. Dr. Cao is an Associate Professor in the Department of Medical Microbiology, Immunology and Cell Biology at Southern Illinois University (SIU) School of Medicine, USA, and a member of the Simmons Cancer Institute. He, as an author/co-author, has been involved in the publication of over 70 articles in various journals, having total number of citations of around 1,770, and he also has 3 patents. Dr. Cao was the recipient of AACR - Aventis Scholar-in-Training Award (2002) and AACR - AstraZeneca Scholar-in-Training Award (2003).

Dr. Chittiboyina holds appointment as Assistant Director at the National Center for Natural Products Research, University of Mississippi, with a broad background in organic chemistry, with specific training and expertise in medicinal chemistry. Dr. Chittiboyina has several international patents and has contributed to book chapters on medicinal chemistry and safety of phytochemicals. He has authored over 100 peer reviewed publications in various peer-reviewed journals involving many aspects of natural and biologically active compounds; biogenesis of secondary metabolites; synthesis and structure activity relationships (SAR); development of non-animal alternative methods in toxicology and application of computer-aided drug design techniques.

Dr. Lu-Qi Huang obtained his Ph.D. degree (1995) from Faculty of Pharmacy, Peking Union Medical University, Beijing, China. Since 2002, Dr. Huang is Director in the Institute of Chinese Materia Medica at China Academy of Chinese Medical Sciences. Furthermore, since 2008, he is Vice President of China Academy of Chinese Medical Sciences. His research interests involve Chinese medicine resources and molecular pharmacology. He, as an author/co-author, has published more than 540 articles in various journals, having a significant number of total citations, i.e. around 3,400. He has also published 9 monographs, and granted / applied 7 intellectual property rights.

Dr. Khan Usman ghani earned MPharm from Osaka Universty, Japan and obtained PhD in Pharmacy from the University of Karachi. Currently he is Consultant at Herbion Pakistan (Pvt) Limited, Karachi and Visiting Professor in Pharmacognosy and Practice and Practice at Jinnah University for Women, Karachi, Pakistan. He has published more than 300 research paper and 34 books. Dr. Usmanghani is the Editor of Journal of Pharmacy and Pharmaceutical Sciences published by Rayazuddin Research and Development Society Jinnah University for Women, Karachi.

Min Ye obtained his Ph.D. degree in Pharmacognosy from Peking University in 2013. He joined the School of Pharmaceutical Sciences at Peking University as an Associate Professor in 2007, and was promoted to Professor in 2012. His research interest is focused on the discovery of bioactive compounds of Chinese herbal medicines, and biocatalysis of bioactive natural products. He has published over 150 peer-reviewed research articles, which have been cited by over 2500 times.

Dr. Zulfiqar Ali obtained his M.S. degree from Punjab University, Pakistan, and his Ph.D. degree from Karachi University, Pakistan. Since Nov 2004, Dr. Ali is Research Scientist in the National Center for Natural Products Research at The University of Mississippi, USA. His interest mainly involves Natural Product Chemistry (Isolation and structure elucidation of constituents from dietary supplements that may be useful as therapeutics or chemical markers). He, as an author/co-author, has published more than 230 articles in various journals, having total number of citations of around 1,960.

Amoo holds a PhD degree in Botany from University of KwaZulu-Natal, South Africa and an MSc (Botany) from Obafemi Awolowo University, Nigeria. He is a Postdoctoral Research Fellow at the Research Centre for Plant Growth and Development, School of Life Sciences, University of KwaZulu-Natal, Pietermaritzburg. He is a recipient of Claude Leon Foundation, University of KwaZulu-Natal and South Africa National Research Foundation Postdoctoral Fellowships. He has many papers published in ISI-rated journals and has presented many papers at both national and international conferences.

Dr. Shun-Wan CHAN obtained a doctorate (Ph.D.) in Pharmacology from the Chinese University of Hong Kong. Currently, Dr. Chan is an Associate Professor in the Technological and Higher Education Institute of Hong Kong. He also serves as an Associate Director in State Key Laboratory of Chinese Medicine and Molecular Pharmacology, The Hong Kong Polytechnic University. He has published more than 100 scientific publications. His research focuses on studying the pharmacological mechanisms of functional foods on preventing chronic diseases, Chinese medicine, microbiology and toxicology.

Debprasad Chattopadhyay, Scientist G & Director of ICMR-National Institute of Traditional Medicine, unveiled the health care wisdom of ethnic medicines of India by establishing personal relationship with diverse tribal communities. His work on scientific validation of purity, safety and potency of useful ethnomedicines with molecular mechanism of action is globally acclaimed. Dr Chattopadhyay published 127 Research papers in peer-reviewed Journals of repute with Reviews and Chapters, Books (4), patents (7), popular articles (54). He is in the Editorial Board and Reviewer of several prestigious Journals; Examiner, PhD Guide, visiting Faculty and recipient of several awards. Dr Chattopadhyay (h-Index: 29; i10-Index: 59; Citations: 2715) is the Fellow of British Society for Antimicrobial Chemotherapy, and Member Review & Approval Committee of DST.

Dr. M. Iqbal Choudhary is a Distinguished National Professor of Organic Chemistry and Director at International Center for Chemical and Biological Sciences (H. E. J. Research Institute of Chemistry and Dr. Panjwani Center for Molecular Medicine and Drug Research). He is among the most prominent scientists of Pakistan, recognized for his original contributions in the fields of natural products and bioorganic chemistry. He has written and edited 50 books, most of which have been published in USA and Europe. He is also the author of over 900 research papers and chapters in top international science journals of the West, as well as 43 US patents. The cumulative impact factor of his publications is over 1,750. This is by far the largest number of quality publications from any scientist in Pakistan. He has been among the most cited scientists of Pakistan in last five years with citations exceeding 11,000 (h-Index: 41).

Dr. Abid Hamid Dar, Ph.D., is currently Senior Scientist (Faculty) of Cancer Epigenetics in the Cancer Pharmacology Division (IIIM) at Indian Institute of Integrative Medicine, Jammu, Kashmir (since Apr 2008). His main skills and expertise are in the areas of PCR, Cell Culture, Gene Expression, Western Blot Analysis, Cancer Biology, Molecular Biology, Flow Cytometry, Molecular Cell Biology, Immunohistochemistry, and Cell Signaling. Dr. Hamid, as an author/co-author, has published more than 70 articles in various journals, having total number of citations of around 940. He has received the following awards (among others): AACR-2015 Travel Grant Award (Biotechne), Young Scientist Award from State, Science & Technology for 2012, etc.

Prof. Dr. James Hamuel Doughari holds a doctorate (Ph.D.) in Environmental Health from the Cape Peninsula University of Technology, Cape Town, South Africa and a Masters Degree in Medical Microbiology from the Federal University of Technology, Yola, Nigeria. He is currently an Associate Professor of Medical Microbiology and Lecturer at the Department of Microbiology, Modibbo Adama University of Technology, (MAUTECH) Yola, Nigeria where he is presently the Head of Department. He is also the Deputy Dean School of Life Sciences (SLS) MAUTECH, Yola and has published more than 50 scientific publications.

Dr. Dayue Darrel Duan, MD, PhD, FAHA, is a Professor of Pharmacology in the Department of Pharmacology and Principle Investigator of the Laboratory of Phenomics in the Center for Molecular Medicine and the Center for Cardiovascular Research at University of Nevada Reno School of Medicine. Dr. Duan has made significant original contributions to the biophysics, physiology, pharmacology, and molecular biology of ion channels, especially anion channels, in the cardiovascular system. His current research is focusing on the application of phenomics in precision medicine and drug discovery. Dr. Duan has delivered over 200 invited lectures and seminars throughout the world, and has published more than 90 peer-reviewed papers and book chapters.

Prof. Anwar H Gilani is a distinguished Pharmacologist, holding the positions of Chairman, Pakistan Council for Science and Technology, who made break through discoveries in the field of ethnopharmacology. He has to his credit co-editor of two WHO Books on Essential Medicine and 450 articles attracting over 13,000 citations with an h-index of 61 (based on google scholar). He supervised research of 20 PhDs and occupied 1st National ranking in the field of Pharmaceutical Sciences. He is a Member, Editorial Boards of 10 reputed journals including Journal of Ethnopharmacology and has been invited/plenary speaker at 80 international conferences.

Dr. Michael J. Gonzalez is Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the University of Western States. Dr. Gonzalez is a Fellow of the American College of Nutrition, and has authored over 200 scientific publications. He has obtained several research awards for his work on Nutrition and Cancer. He is currently Co- Director of RECNAC II project, and Research Director of the InBioMed Project Initiative. Dr. González is one of the founders of InBioMed, leaders in the development of non-toxic chemotherapy treatments for cancer.

Associate Prof. Dr. Wandee Gritsanapan got a Ph.D. in Pharmacy from the University of Queensland, Australia and a Master of Science in Pharmacognosy from Chulalongkorn University, Thailand. Dr. Gritsanapan was an Associate Prof. at Department of Pharmacognosy, Faculty of Pharmacy, Mahidol University. Currently she has retired from Mahidol University and working at Phyto Product Research in Bangkok. Dr. Gritsanapan has published more than 130 original scientific papers, 350 scientific abstracts (presented at the conferences of medicinal plants and natural products) and more than 10 books/book chapters both in Thai and English languages. Dr. Gritsanapan is currently an editorial advisory board of the journal ‘Current Traditional Medicine’.

Dr. Yeun-Hwa Gu is working as Professor of the department of radiation oncology, Graduate School of Health Science, Junshin Gakuen University, Japan. Dr. Yeun-Hwa Gu has worked as Professor of Suzuka Medical Science University's Department of Health and Sanitation. He graduated from the University of Tokyo. He is working as an academic advisory committee of the Korea Society of Health Sciences and academic director of Korean Ultrasound Cancer Therapy (HIFU) Society and co-researcher of Russia Space Radiation Chemistry Protection Study Group. He published more than 250 papers in various peer-reviewed journals.

Dr. Prasoon Gupta has over 19 years of research experience in the field of Traditional Indian Medicines, and terrestrial, microbial and marine natural products chemistry. Dr. Gupta obtained his Ph.D. degree in Natural Product Chemistry in 2007 from Central Drug Research Institute, India. His Ph.D. work, describing mainly the discovery of very promising anti-stress agents from plant, is an exceptional contribution to Ayurvedic drug research. He has delivered several invited talks in India and abroad. He is also associated with national and international journals in different capacities.

Mahabir Gupta holds a Ph. D. degree from Washington State University and a postdoctoral Alexander von Humboldt Fellowship at the University of Munich. His prizes inter alia include AAAS International Science Cooperation Award, Interciencia Award for Health Sciences, and National Research Excellence Award Panama. He is member of Royal Academy of Pharmacy of Spain, Iberoamerican Academy of Pharmacy, Latin – American Academy of Sciences, and distinguished scientist of SENACYT Panama. He has over 250 publications in peer- reviewed journals. He is on the advisory Committee of Current Traditional Medicine.

I currently work in the Plant Biochemistry department @ Lab of Wood and Crops Biology (INRA USC1328), my research focused on specialized plant metabolites (Phytochemistry) and Plant Biotechnology. I currently develop research projects that aim at elucidating the production of specialized metabolites from plants, with a particular emphasis of plant natural products with pharmaceutical or cosmeceutical interests. My work focus: - at fundamental level on the elucidation of biosynthetic mechanisms of plant natural products using both molecular biology and phytochemisrty approaches, - at applied level the industrial exploitation of plant natural products using metabolic engineering approaches (in particular the bioproduction of plant cosmetic compounds by different plant in vitro systems).

Ching-Liang Hsieh graduated from the School of Chinese Medicine, China Medical University (CMU), Taichung City, Taiwan, in 1978 with a Bachelor of Medicine. He is licensed in both Western medicine and traditional Chinese medicine (TCM). He is an editorial board member of Evidence-Based Complementary and Alternative Medicine and an associate editorial board member of the Journal of Traditional and Complementary Medicine. Professor Hsieh has two PhD degrees: one from Kyushu University, Japan (1995), and one from Guangzhou Chinese Medicine University, China (2004). He has published more than 200 papers.

Prof. Hua Zhou is currently appointed as Full Professor in the State Key Laboratory of Quality Research in Chinese Medicine, and as Associate Dean of the Faculty of Chinese Medicine, at Macau University of Science and Technology, China. His major research areas include immunopharmacology, cardiovascular pharmacology, pharmacokinetics, and bioactivity-guided quality research of Chinese medicines. Prof. Zhou has published over 105 SCI articles, 45 Chinese articles, and 13 books, and he has been granted 25 international or Chinese patents. Furthermore, he has been awarded Second Prize of the National Science & Technology Progress Award of China, and First Prize of the Nature and Science Category of 2014 Ministry of Higher Education Outstanding Scientific Research Output Awards.

Dr . Kong obtained a doctorate (Ph.D.) in Medicinal Chemistry from Shenyang College of Pharmacy, China. Dr. Kong is a Changjiang Distinguished Professor and an awardee of the National Science Fund for Distinguished Young Scholars of China. Currently Dr. Kong is also a professor and vice president in China Pharmaceutical University. He has published more than 500 scientific publications and is a named inventor of 20 issued patents. He is the executive editor-in-chief of the Chinese Journal of Natural Medicines and the member of the editorial boards of Journal of Asian Natural Product Research, Acta Pharmaceutica Sinica, Chinese Pharmaceutical Journal and China Journal of Chinese Materia Medica.

Dr. Pradeep Kumar is presently serving as an Assistant Professor at Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda. He has published 50 research and review articles in Journals of international repute. He has a cumulative impact factor more than 100 and h-index 14. His research interests include design of drugs using Computer Aided Drug Design methodologies, their synthesis and antimicrobial and anticancer evaluation.

Dr. Xing-Cong Li is a Principal Scientist in the National Center for Natural Products Research and Research Associate Professor of Pharmacognosy at The University of Mississippi. Dr. Li received his B.S. in Medicinal Chemistry from Shanghai Medical University, M.S. in Phytochemistry from Kunming Institute of Botany, Chinese Academy of Sciences, and Ph.D. in Pharmaceutical Science from Hiroshima University. Dr. Li’s research focuses on the isolation, structure elucidation, and synthesis of anti-infective natural products. He has published more than 100 peer-reviewed journal articles/book chapters and served the scientific community as an editorial board member for several journals.

Prof. Liu Xinmin obtained his Ph.D and Master Degree from Peking Union Medical College, Beijing, China. Prof. Liu Xinmin is currently the Professor in the Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences (CAMS), China, he has been working on Neuro-pharmacology, safety evaluation on herbal medicine. Prof. Dr. Liu has been appointed as the Member, Expert Advisory Panel on Traditional Medicine, World Health Organization since 2008, he has published more than 120 academic papers and is named inventor of 6 Chinese patents.

Dr Lobo is a Pharmacognosist, obtained a doctorate (Ph.D.) in Pharmacognosy (Natural product) from Manipal University, Manipal, Karnataka, India. Dr. Lobo also holds an M.Pharm degree in Pharmacognosy from Manipal University and B.Pharm degree in Pharmaceutical Sciences from Mangalore University, Karnataka, India Currently Dr.lobo is working as a Associate Professor in Pharmacognosy , Manipal College of Pharmaceutical Sciences, Manipal University, he is also an Associate Editor for BMC Complementary and Alternative Medicine publish by BioMed Central an impact factor journal, Editorial board member for Current Traditional Medicine, published by Bentham science publishers and Editorial board member for Journal of Bioequivalence Studies, Annex publishers. He has published more than 50 scientific publications and contributed chapters to the book

Professor Lu Aiping is Chair Professor â Dean of School of Chinese Medicine, Hong Kong Baptist University. His research interests focus on the clinical evaluation with RCT focusing on rheumatoid arthritis with TCM pattern diagnosis, standardization of Chinese medicine diagnosis, and research and development of new drugs. Prof. Lu has published more than 30 books and over 500 articles, including 200 articles in SCI journals such as Nature Medicine, Biomaterials, Briefings in Bioinformatics, Clinical Pharmacology and Therapeutics, Scientific Reports, Journal of Proteomic Research. Over the years, he obtained more than 60 patents from his research activities.

Prof. Xiao is currently a Post doctor at Peking University. He did his PhD in 2005 from Sheng Yang Pharmaceutical University. His fields of expertise are Biotransformation of bioactive natural products, Isolation and structural determination of chemical constituents from natural resources, the metabolism of natural products, QC of medicinal herbs by HPLC analysis. He has worked on the investigation on the manual incubation of rare medicinal plants and fungi. He also investigated phytochemistry of 5 traditional Chinese medicines, and purified and identified over 130 chemical constituents by modern chromatographic and spectral techniques, 15 of which are new chemical entities.

Dr. Marnewick obtained a Ph.D. in Biochemistry from the University of Stellenbosch, South Africa. Currently Dr. Marnewick is a full research professor at the Cape Peninsula University of Technology, Cape Town, South Africa where she is the Director of the Oxidative Stress Research Centre. Her main research focus for the past 20 years has been the health promoting properties of Rooibos and Honeybush, two indigenous herbal teas with specific focus on oxidative stress-induced diseases/conditions and chemoprevention. The research she and her team has conducted to date have resulted in a number of novel contributions to the understanding of Rooibos.

Professor Shivananda B. Nayak, M.Sc., Ph.D., NRCC-CC, FACB, FAGE, FABMS, is currently Deputy Dean of Graduate Studies and Research in the Faculty of Medical Sciences at The University of The West Indies, St. Augustine, Trinidad and Tobago. His research topics mainly involve Internal Medicine (General Medicine), Nutrition and Dietetics, and Diabetology. He, as an author/co-author, has published around 30 articles in various journals, having total number of citations of around 240. In Oct 2013, he won the Vice Chancellors Award for Excellence in Teaching.

Professor Bhushan Patwardhan has made original contributions to an important area of evidence-based traditional medicine, ethnopharmacology, drug discovery, development and integrative medicine. He is a Fellow of National Academy of Medical Sciences (India). He is founder Editor-in-Chief of Journal of Ayurveda and Integrative Medicine published by Elsevier and top most cited authors in his area. He has been consultant to WHO Geneva, member of task force for National Knowledge and Planning Commissions among many other important assignments. He is recipient of many awards and orations including Sir Ram Nath Chopra Oration, Waldeimar Haffkine Oration among many other. He has guided 19 PhD students, 6 Indian Patents, 2 US Patents and over 120 research publications.

Dr. Rahimi obtained Pharm.D. from Shiraz University of Medical Sciences and Ph.D. in Traditional Pharmacy from Tehran University of Medical Sciences, Tehran, Iran. Currently Dr. Rahimi is a faculty member in Tehran University of Medical Sciences. She has published about 100 scientific papers. Dr. Rahimi is editor-in- chief of Traditional & Integrative Medicine, an international official journal of School of Traditional Medicine, Tehran University of Medical Sciences. She is also editor of 4 international scientific journals.

Dr. Paolo Roberti di Sarsina graduated in Medicine in 1979 in the School of Medicine at the University of Bologna and specialized in Psychiatry in 1983 at the same University. He is the founder of the not-for-profit network Permanent Committee of Consensus and Coordination for Non-Conventional Medicine in Italy (established in Bologna on December 5, 2003). From 2006, he is an Expert for Non-Conventional Medicine to High Council of Health, Ministry of Health, Italy, and is the Founder and President of the Italian Charity "Association for Person Centred Medicine". Dr. Roberti di Sarsina has authored/co-authored more than 30 publications, having around 225 total citations. Furthermore, he has been one of the 16 participants of the EU funded (FP7) CAMbrella Consortium.

Dr. Robles Zepeda obtained a doctorate (Ph.D.) in Plant Biotechnology in the Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional at Irapuato, México. Currently Dr. Robles Zepeda is Titular Professor in the Departamento de Ciencias Químico Biológicas de la Universidad de Sonora, México. He has published about 40 scientific publications ando 10 master's thesis and doctoral directed.

Tuhinadri Sen is currently working as an Professor in the Department of Pharmaceutical Technology, Jadavpur University , Kolkata. Dr. Sen is presently working with the medicinal plants from the Sunderban mangroves of West Bengal and also coordinates a number of collaborative research programmes. He has also acquired expertise in the recombinant expression of G-protein coupled receptor. He has authored many research articles in peer reviewed journals and has also contributed scientific articles in different books. He is a member of the editorial Advisory Board of several journals published from India and abroad and has been a reviewer of National and International Journals.. He has received many distinction including University Medal, M.L Khorana Medal, G P Nair award. He has been the recipient of INSERM Poste Vert Fellowship (IGF, Montpellier). Dr. Sen also received the Erasmus Mundus India Academic Staff Fellowship for working in KU Leuven (Belgium) and also the Erasmus Mundus Europe – Asia (EMEA) Fellowship for working in UCD, Dublin.

Dr. Xu Shen is Head of Department (Pharmacology Department III), Shanghai Institute of Materia Medica, Shanghai, China. He is focused on the research of “target identification and validation” and “macromolecule-small molecule interaction based drug design and screening” by targeting key proteins involved in metabolic and infectious diseases. It is tempting to search for new leads and drug candidates, and has recently successfully constructed two technology platforms, namely, target identification and validation as well as structural biology based drug design. Dr. Thounaojam has around 296 scientific publications to her credit.

Dr. K.N.S. Sirajuddeen obtained his Ph.D. degree (1998) in Biochemistry from University of Madras, India. Dr. Sirajudeen is currently Senior Lecturer in the School of Medical Sciences (Health Campus) at the Universiti Sains Malaysia. His professional affiliations include membership in the Malaysian Association of Clinical Biochemists (2004-present) and in The Malaysian Society of Pharmacology & Physiology (2006-present). He, as an author/co-author, has published over 50 articles in various journals, having total number of citations of around 680. He has published mainly in the subject areas of Biochemistry, Genetics, Molecular Biology, Pharmacology, Toxicology and Pharmaceutics.

Dr. Shirley Anne Telles obtained her Ph.D. degree (1992) in Neurophysiology from National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore University, India. Since 2007, she is Director of Research at Patanjali Research Foundation, Patanjali Yogpeeth, Haridwar, India. Previously, from 2007 to 2012, she was Principal Investigator at the Indian Council of Medical Research Center for Advanced Research in Yoga and Neurophysiology, Swami Vivekananda Yoga Research Foundation, Bangalore, India. She, as an author/co-author, has published more than 140 articles in various journals (having total number of citations of around 2,190), over 18 book chapters and 4 books. She has published mainly in the fields of Psychology, Biochemistry, Genetics and Molecular Biology.

Dr. Menaka Thounaojam obtained her M.Sc and Ph.D. in Zoology degrees from The Maharaja Sayajirao University of Baroda during the period of 2005-2011. Since 2014, she is Postdoctoral Research associate at Department of Biochemistry and Cancer Biology, Meharry Medical College. She is also associated with Department of Ophthalmology, Augusta University. Dr. Thounaojam has around 66 scientific publications to her credit.

Prof. Karl Tsim is a Chair Professor of Division of Life Science, and the Director of Center for Chinese Medicine R&D at the university. He has published over 350 scientific papers and serves as editors for many scientific journals internationally. His works on Chinese herbal medicine have been awarded twice for Research Excellence in Natural Sciences from Ministry of Education of China. He also serves as an adviser/consultant/member to various organizations, both nationally and internationally, in the standardization of Chinese herbs, which include WHO and HKSAR Government in Testing and Certification of Chinese herbs.

Prof. Xijun Wang, male, born in December 1961, PhD in Japan Hokkaido College of Pharmacy in 1998. Now, he has been serving as doctoral tutor and vice president of Heilongjiang University of Chinese Medicine, general director of Chinmedomics Research Center. He was granted National Science and Technology Progress Award in 2002, 2006 and National Technology Invention Award in 2009. He also was awarded as "National Excellent Scientist", "National excellent teachers", "youth star of national medical science and technology" and "WuJiePing Medical Innovation Award", etc. He published more than 300 academic papers, including 180 SCI papers.

Prof. Yitao Wang completed his postgraduate study (Pharmacology, 1986) at Chongqing Medical University. Prof. Wang is the founding Director of the Institute of Chinese Medical Sciences (ICMS) at the University of Macau (UM) and of the State Key Laboratory of Quality Research in Chinese Medicine (UM). He is known internationally for his pioneering contributions to the modernisation of Chinese medicine (CM), with an emphasis on systematic evaluation and quality control of CM. He has a long-standing interest in integrating CM research with the cutting-edge areas of systems pharmacology and molecular pharmaceutics. In the past 10 years, Prof. Wang has published 200+ research papers in international peer-reviewed journals, authored 230+ papers in Chinese, and (co-)edited 16 academic books.

He is Associate Professor, Deputy Director of Institute of Chinese Herbal Medicine Beijing and Associate Director of Integrative Medical Center for Liver Diseases, Beijing 302 Hospital of China His main research focus is the evaluation of drug- and herb- induced liver. My team has developed a new causality identification algorithm for HILI diagnosis, new approaches for in vitro and in vivo evaluation of hepatotoxicity, evaluation models for susceptibility of DILI/HILI. Recently, he established the online database of HILI (hilidatabase.org) in response to a Major Project launched by the NSFC to provide a platform for global collaborative research of HILI.

Dr. Wanying Wu is a professor and doctoral supervisor in Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China. Dr. Wu joined the United States Pharmacopeia as a visiting Scientist in 2013 and took part in the establishment of the Herbal Medicine Compendium. She is now part of the committee of the 11th Chinese Pharmacopoeia Commission. Also Dr. Wu is a member of the USP Herbal Medicines Compendium - East Asia Expert Panel, Director and Secretary General of the Specialty Committee of TCM. She has established 32 TCM standards that have been accepted by U.S. Pharmacopeia or the European Pharmacopoeia.

Zuguang Ye, Head of Center of TCM safety evaluation, Chief professor in pharmacology and toxicology of traditional Chinese medicine(TCM) in China Academy of Chinese Medical Sciences. He is an Approved expert enjoying the government special subsidy provided by The State Council, and also a Chief Scientist in toxicology of TCM in National “973” Project. He has worked on research of pharmacology and toxicology of TCM, including R & D of a new drug from TCM. In the past 30 years, he has finished about 50 key research projects supported by China government, awarded to various grade’s Prize of Scientific and Technological Achievements, and published more than 100 papers.

Dr. Yuan is the Cyrus Tang Professor in the Department of Anesthesia & Critical Care at the University of Chicago. He is a recognized expert in herbal medicine, and is actively researching the benefits and adverse effects of commonly used herbal medicines. Dr. Yuan has published numerous scientific articles, including more than 100 papers on herbal research. In addition, he is the primary Editor of the Textbook of Complementary and Alternative Medicine (1st & 2nd editions)and he serves the Editor-in-Chief of The American Journal of Chinese Medicine. A native of China, Dr. Yuan received his medical degree from Shanghai Second Medical College, and passed the U.S. medical board exams for foreign physicians. He earned a PhD in physiology from the University of Arizona and completed a fellowship in clinical pharmacology at the University of Chicago.

Dr. Jixun Zhan received a Ph.D. in biochemical engineering from East China University of Science and Technology, and conducted postdoctoral training at the University of Arizona and the University of California, Los Angeles. Currently, he is an associate professor in the Department of Biological Engineering at Utah State University. His research is focused on metabolic engineering and natural product biosynthesis. So far he has published three book chapters and 84 peer-reviewed papers in respected journals such as PNAS and Journal of the American Chemical Society.

Dr. Weidong Zhang obtained his Ph.D. degree (1998) from Shanghai Institute of Pharmaceutical Industry, China. Since Sep 2003, Dr. Zhang is Professor in the School of Pharmacy at Second Military Medical University, Shanghai, China. His research interests involve the following: Bioactive components from traditional Chinese medicine (TCM) and compound traditional Chinese medicine; Quality Control of TCM; Metabolism in vivo; Systems biology; and New drug R&D of TCM. His main achievements/awards include: (1) the National Outstanding Young Scientist Foundation of China (2007); and (2) recently authored/co-authored 400 papers.

Dr. Singh is Neurobiologist with a strong background in Biochemistry and Biomedicine. he has dedicated more than 7 years to Neuroscience Research and used animal models system to investigate the therapeutic potential for Alzheimer’s disease using synthetic as well as natural compounds in the Drosophila model system. Currently, He is Founder President of a non-profit organization in India named Indian Scientific Education and Technology Foundation (ISET Foundation) and working in the field of Neurobiology and Biotechnology Research Promotion. The last 7 years research work come up with a couple of nice publications to my credit in journals of international repute like (International Journal of Alzheimer’s Disease, Neurotoxicity Research, Oxidative Medicine and Cellular Longevity, BBRC, Neurochemical Research, Neuroscience Letter, Current Drug Metabolism etc.) and 2 book chapter as mentioned in my CV. Member of the editorial board of several International neuroscience related journals.